Share on

Middle East and Africa Cell Harvesting Systems Market Research Report – Segmented By Application, End-user, Techniques & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: March, 2023
ID: 7897
Pages: 145
Formats: report pdf report excel report power bi report ppt

MEA Cell Harvesting Systems Market Size (2022 to 2027)

The size of the Middle East & Africa Cell Harvesting Systems Market is projected to value USD 0.83 billion by 2027 from USD 0.57 billion in 2022, growing at a CAGR of 7.76% from 2022 to 2027.

The proliferation of chronic and contagious diseases is majorly driving the MEA cell harvesting systems market. Also, the rise in biopharmaceutical and biotechnology technologies are contributing the market growth. 

On the other hand, the growing emphasis on cell-based therapies and rising healthcare expenditure propel the market growth during the forecast period. Product launches, product approvals, and other organic growth initiatives such as patents and events are being prioritized by several firms. Acquisitions, partnerships, and collaborations are examples of inorganic growth strategies shown in the market. These initiatives have paved the path for market participants to expand their business and consumer base.

 In addition, increasing investments and funding by the government and private organizations in regenerative medicine and cell-based research activities are expected to provide lucrative growth opportunities to the market. However, with the growing demand for customized process trays in the regional market, market players in the Cell Harvesting Systems Market are expected to have attractive growth opportunities in the future years.

Owing to its beneficial factors in regenerative medicine, the market is expected to expand significantly during the forecast period. In addition, the increasing frequency of blood cancer and anemia has resulted in a rise in bone marrow transplant treatments which is driving the market. Furthermore, the proliferation of cardiovascular diseases in the region's aging population is contributing to market growth. Over the last decade, there has been a substantial increase in stem cell-based research, boosting demand for stem cell harvesting for research. Various technical advancements are projected to drive new and better technologies with improved outcomes, propelling the cell harvesting systems market over the forecast period. Many firms are focused on cardiac tissue regeneration by injecting cell grafts of adult stem cells from patients to create regenerative medications that are expected to expand the market growth.

However, the High price, lack of reimbursement policies, and immune rejection are key factors that are expected to hamper the MEA cell harvesting systems market.

This research report on the Middle East and Africa Cell Harvesting Systems Market has been segmented and sub-segmented based on the following categories:

By Application:

  • Bone Marrow
  • Umbilical Cord
  • Adipose Tissue
  • Peripheral Blood

By End User:

  • Academic Institutes
  • Hospitals
  • Diagnostic Labs
  • Research Centers

By Technique:

  • Blastomere Extraction
  • Altered Nuclear Transfer

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Cell harvesting systems market is projected to have a promising share in Middle East Africa. Cell harvesting is a critical step in the biopharmaceutical manufacturing process that directly impacts product quality and downstream operations in MEA. Over the years, the demand for cell harvesting has been very high in the MEA. Growing expansion of key market players in the developing countries in MEA such as South Africa, Saudi Arabia, and UAE are expanding the regional market growth.

South Africa dominated the cell harvesting systems market and accounted for the highest share in the region. The rising incidence of chronic diseases, increasing aging population, and government investments in cell-based research are propelling the market growth. In addition, growing awareness, increasing healthcare expenditure are further propel the market growth.

On the other hand, emerging countries such as UAE and Saudi Arabia will witness a promising share in the cell harvesting market. Improving healthcare infrastructure, increasing the adoption of technological advancements in the healthcare sectors are expected to drive the market growth.


A few of the notable market participants dominating the MEA cell harvesting systems market profiled in this report are Avita Medical; Tomtec; Terumo Corporation; Perkin Elmer, Inc; Argos Technologies, Inc; Bertin Technologies; Arthrex, Inc; Brand GmBh + CO KG; Thomas Scientific; and Tereflex, Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample